BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29489735)

  • 21. RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome.
    Bögershausen N; Tsai IC; Pohl E; Kiper PÖ; Beleggia F; Percin EF; Keupp K; Matchan A; Milz E; Alanay Y; Kayserili H; Liu Y; Banka S; Kranz A; Zenker M; Wieczorek D; Elcioglu N; Prontera P; Lyonnet S; Meitinger T; Stewart AF; Donnai D; Strom TM; Boduroglu K; Yigit G; Li Y; Katsanis N; Wollnik B
    J Clin Invest; 2015 Sep; 125(9):3585-99. PubMed ID: 26280580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autism spectrum disorder in Kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases.
    Parisi L; Di Filippo T; Roccella M
    Minerva Pediatr; 2015 Aug; 67(4):369-75. PubMed ID: 26129805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Under the mask of Kabuki syndrome: Elucidation of genetic-and phenotypic heterogeneity in patients with Kabuki-like phenotype.
    Paderova J; Drabova J; Holubova A; Vlckova M; Havlovicova M; Gregorova A; Pourova R; Romankova V; Moslerova V; Geryk J; Norambuena P; Krulisova V; Krepelova A; Macek M; Macek M
    Eur J Med Genet; 2018 Jun; 61(6):315-321. PubMed ID: 29307790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal and perinatal history in Kabuki Syndrome.
    Rosenberg CE; Daly T; Hung C; Hsueh I; Lindsley AW; Bodamer O
    Am J Med Genet A; 2020 Jan; 182(1):85-92. PubMed ID: 31654559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.
    Wang Y; Li N; Su Z; Xu Y; Liu S; Chen Y; Li X; Shen Y; Hung C; Wang J; Wang X; Bodamer O
    Am J Med Genet A; 2020 Apr; 182(4):640-651. PubMed ID: 31883305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobehavioral features in individuals with Kabuki syndrome.
    Caciolo C; Alfieri P; Piccini G; Digilio MC; Lepri FR; Tartaglia M; Menghini D; Vicari S
    Mol Genet Genomic Med; 2018 May; 6(3):322-331. PubMed ID: 29536651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth Hormone Therapy in Children with Kabuki Syndrome: 1-year Treatment Results.
    Schott DA; Gerver WJM; Stumpel CTRM
    Horm Res Paediatr; 2017; 88(3-4):258-264. PubMed ID: 28793284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KDM6A point mutations cause Kabuki syndrome.
    Miyake N; Mizuno S; Okamoto N; Ohashi H; Shiina M; Ogata K; Tsurusaki Y; Nakashima M; Saitsu H; Niikawa N; Matsumoto N
    Hum Mutat; 2013 Jan; 34(1):108-10. PubMed ID: 23076834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia.
    McVeigh TP; Banka S; Reardon W
    Clin Dysmorphol; 2015 Oct; 24(4):135-9. PubMed ID: 26049589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
    Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
    J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kabuki syndrome: international consensus diagnostic criteria.
    Adam MP; Banka S; Bjornsson HT; Bodamer O; Chudley AE; Harris J; Kawame H; Lanpher BC; Lindsley AW; Merla G; Miyake N; Okamoto N; Stumpel CT; Niikawa N;
    J Med Genet; 2019 Feb; 56(2):89-95. PubMed ID: 30514738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2).
    Banka S; Lederer D; Benoit V; Jenkins E; Howard E; Bunstone S; Kerr B; McKee S; Lloyd IC; Shears D; Stewart H; White SM; Savarirayan R; Mancini GM; Beysen D; Cohn RD; Grisart B; Maystadt I; Donnai D
    Clin Genet; 2015 Mar; 87(3):252-8. PubMed ID: 24527667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kabuki syndrome revisited.
    Bokinni Y
    J Hum Genet; 2012 Apr; 57(4):223-7. PubMed ID: 22437206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel KMT2D mutation resulting in Kabuki syndrome: A case report.
    Lu J; Mo G; Ling Y; Ji L
    Mol Med Rep; 2016 Oct; 14(4):3641-5. PubMed ID: 27573763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong.
    So PL; Luk HM; Yu KPT; Cheng SSW; Hau EWL; Ho SKL; Lam STS; Lo IFM
    Am J Med Genet A; 2021 Mar; 185(3):675-686. PubMed ID: 33314698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [One novel pathologic variation in
    Qiu SW; Yuan YY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):820-824. PubMed ID: 31446696
    [No Abstract]   [Full Text] [Related]  

  • 37. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome.
    Lederer D; Grisart B; Digilio MC; Benoit V; Crespin M; Ghariani SC; Maystadt I; Dallapiccola B; Verellen-Dumoulin C
    Am J Hum Genet; 2012 Jan; 90(1):119-24. PubMed ID: 22197486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging in Kabuki syndrome and another KMT2D-related disorder.
    Stadelmaier RT; Kenna MA; Barrett D; Mullen TE; Bodamer O; Agrawal PB; Robson CD; Wojcik MH
    Am J Med Genet A; 2021 Dec; 185(12):3770-3783. PubMed ID: 34369642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A de novo KMT2D mutation in a girl with Kabuki syndrome associated with endocrine symptoms: a case report.
    Moon JE; Lee SJ; Ko CW
    BMC Med Genet; 2018 Jun; 19(1):102. PubMed ID: 29914387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Patient with Kabuki Syndrome Mutation Presenting with Very Severe Aplastic Anemia.
    Tamura S; Kosako H; Furuya Y; Yamashita Y; Mushino T; Mishima H; Kinoshita A; Nishikawa A; Yoshiura KI; Sonoki T
    Acta Haematol; 2022; 145(1):89-96. PubMed ID: 34515044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.